News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Startup Syndexa Pharmaceuticals Corp. Launches Targeting Obesity
November 29, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
A group of scientists from Harvard University and other top schools have formed Syndexa Pharmaceuticals Corp., a biotechnology startup developing treatments for conditions related to obesity, according to Harvard.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
Startups
MORE ON THIS TOPIC
Layoff Tracker
Gilead guts Arcellx team as BioNTech plant closures will wipe out 1,860 jobs
May 6, 2026
·
49 min read
·
BioSpace Editorial Staff
IPO tracker
Odyssey eyes $236M for renewed Nasdaq bid, Seaport docks on Nasdaq
May 5, 2026
·
12 min read
·
Editorial Team
Layoffs
Passage cuts 75% of workforce after FDA trial design request
May 4, 2026
·
1 min read
·
Angela Gabriel
Insights
What makes life science angel investment work?
April 30, 2026
·
1 min read
·
Jennifer C. Smith-Parker